GEN Exclusives

More »

GEN Poll

More »
Jan 13, 2014

Wall Street Losers

GEN recently published a list of the top 10 worst stock performers of 2013—the 10 biotech, pharma, tools/tech, and services (CROs) company stocks whose prices fell the most during the past year. Which of the firms on this list do you think could turn things around in the near future?

Which of our 10 Wall Street Losers do you think is most likely to recuperate and go back up in value?

Amarin
 
  8.6%
Amicus Therapeutics
 
  6.5%
Ariad Pharmaceuticals
 
  40.3%
Aveo Oncology
 
  13.7%
BG Medicine
 
  7.2%
GTx
 
  5.0%
Pernix Therapeutic Holdings
 
  2.9%
Prima BioMed
 
  7.2%
Vical
 
  5.8%
XTL Biopharmaceuticals
 
  2.9%

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »